Every vial sitting at the wrong temperature, every container exposing the solution to light, every unnecessary puncture introducing oxygen, all of it chips away at the compound you carefully reconstituted
The market growth of this segment is can be linked to rising demand for safe and effective medications for type 2 diabetes and obesity, growing awareness of patients, rising disposable incomes, increased availability of drugs through widespread retail pharmacy network, government policies such as Pharmaceutical Benefits Scheme (PBS) and customer preference of purchasing drugs from pharmacies
Upendra Sharma , focuses on combining cutting-edge technology with traditional formulations to deliver unmatched results
These estimates are speculative and may change
Biocon Limited Launches GLP-1 Drug Liraglutide in Netherlands After MEB Approval Biocon Limited has successfully launched its GLP-1 peptide Liraglutide in the Netherlands following approval from the Dutch Medicines Evaluation Board (MEB)
The route of administration, as we'll discuss, dramatically alters the required concentration
